Gatske M. Nieuwenhuyzen-de Boer

Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer

Cornelis G. Gerestein, Gatske M. Nieuwenhuyzen-de Boer, Marinus J.C. Eijkemans et al. · European Journal of Cancer · 2009 · 66 citations

Gynecologic Surgery, Surgical Oncology, Primary Cytoreductive Surgery +10

Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: High concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN

Maaike G. Dijkstra, Daniëlle A.M. Heideman, Folkert J. van Kemenade et al. · Journal of Clinical Virology · 2012 · 49 citations

Cervical Cancer Screening, Point-of-care Testing, Cervical Cancer +12

Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands

Gatske M. Nieuwenhuyzen-de Boer, Ward Hofhuis, Nathalie Reesink‐Peters et al. · BMC Cancer · 2019 · 22 citations · Full text

Hyperspectral Imaging for Tissue Classification after Advanced Stage Ovarian Cancer Surgery—A Pilot Study

Sharline M. van Vliet‐Pérez, Nick J. van de Berg, Francesca Manni et al. · Cancers · 2022 · 22 citations · Full text

Surgical Oncology, Engineering, Oncologic Imaging +25

Factors Predicting 30-Day Grade IIIa–V Clavien–Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study

Malika Kengsakul, Gatske M. Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun et al. · Cancers · 2022 · 15 citations · Full text

Surgical Oncology, Cancer Management, Prognosis +20